alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Idiopathic Parkinson Disease in 10 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, G | 1 |
| Shin, N | 1 |
| Kim, KS | 1 |
| Tamura, H | 1 |
| Sasaki, M | 1 |
| Nakajima, S | 1 |
| Nishio, R | 1 |
| Saeki, N | 1 |
| Katahira, M | 1 |
| Tamano, H | 1 |
| Takeda, A | 1 |
| Pelosi, A | 1 |
| Murray, TK | 1 |
| Whalley, K | 1 |
| Robinson, CS | 1 |
| Ward, MA | 1 |
| Hicks, CA | 1 |
| Lodge, D | 1 |
| Vandergriff, JL | 1 |
| Baumbarger, P | 1 |
| Siuda, E | 1 |
| Gates, M | 1 |
| Ogden, AM | 1 |
| Skolnick, P | 1 |
| Zimmerman, DM | 1 |
| Nisenbaum, ES | 1 |
| Bleakman, D | 1 |
| O'Neill, MJ | 1 |
| Galeffi, F | 1 |
| Bianchi, L | 1 |
| Bolam, JP | 1 |
| Della Corte, L | 1 |
| Calon, F | 1 |
| Rajput, AH | 1 |
| Hornykiewicz, O | 1 |
| Bédard, PJ | 1 |
| Di Paolo, T | 1 |
| Ossowska, K | 1 |
| Luquin, MR | 1 |
| Obeso, JA | 1 |
| Laguna, J | 1 |
| Guillén, J | 1 |
| Martínez-Lage, JM | 1 |
| Klockgether, T | 1 |
| Turski, L | 1 |
| Svensson, TH | 1 |
| Mathé, JM | 1 |
| Nomikos, GG | 1 |
| Schilström, B | 1 |
2 reviews available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Cell-specific α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonism reveals new insights in the development of parkinson's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Glutamic Acid; Humans; Parkinson Disease | 2017 |
The role of excitatory amino acids in experimental models of Parkinson's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Catalepsy; Disease M | 1994 |
8 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Galvanic vestibular stimulation down-regulated NMDA receptors in vestibular nucleus of PD model.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Electric Stimulation; Parkinson D | 2022 |
Reactive oxygen species produced by Zn
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dopaminergic Neurons; Edema; Hydr | 2023 |
LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Ac | 2003 |
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.
Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; | 2003 |
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Topics: Aged; Aged, 80 and over; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Binding Sites; Bi | 2003 |
The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Ac | 1993 |
Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Basal Ganglia; Cycloleucine; Elec | 1993 |
Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anim | 1998 |